Terns’ oral weight-loss drug has shown promising results in early-stage studies
Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9 per cent in an early-stage study, joining drugmakers vying for a share of the lucrative weight-loss market, and its shares rose 27 per cent on Monday.
POPULAR POSTS
Portugal declares risk as wildfires hit the north of the country
September 17, 2024
UK to appoint nature envoy
September 17, 2024
Death tolls rises as Central Europe floods
September 17, 2024
LIVE STREAM